Blog
Unifying Data for Pharmaceutical Commercialization in the New Era
2 Minute Read
The pharmaceutical industry stands at a pivotal juncture, navigating a complex landscape marked by evolving drug archetypes, escalating costs, and stringent regulations. In this dynamic environment, the ability to...
Taming Launch Data Chaos: Why Your Bespoke CDW Can’t Keep Pace
2 Minute Read
The pharmaceutical landscape, particularly during launch, is drowning in data. Specialty Pharmacy (SP) and Specialty Distributor (SD) data streams are critical lifelines, offering insights into prescribing behavior, patient access,...
How Pharma Manufacturers Can Navigate the 340B Program & Stay Up...
7 Minute Read
The 340B program stands out as one of the most dynamic and complex government programs. We will explore how and why we got here.
State Price Transparency: How to Navigate Evolving Laws
4 Minute Read
At the recent Pricing and Contracting USA 2025 Conference, industry leaders came together to address the growing complexity and operational challenges of state price transparency compliance.
Unpacking Trump’s Drug Pricing Executive Order & the 2026 Part D...
8 Minute Read
This month, we offer commentary on two topics around Unpacking Part D Redesign in 2026 and Trump’s Drug Pricing Executive Order.
Optimizing Pharma Net Revenue Under New Market Dynamics
4 Minute Read
This year's Asembia conference was highly impactful, offering deep insights into pharmaceutical manufacturers' top challenges and future commercial data needs, particularly highlighting the growing demand for real-time, integrated data...
Bringing Clarity to the Complexities of Pharma Commercial Data at Asembia...
4 Minute Read
This year's Asembia conference was highly impactful, offering deep insights into pharmaceutical manufacturers' top challenges and future commercial data needs, particularly highlighting the growing demand for real-time, integrated data...
What MFN Pricing Initiatives Mean for Manufacturers: Key Insights from the...
3 Minute Read
May 20, 2025, the U.S. Department of Health and Human Services (HHS) issued a significant update on the Executive Order “Delivering Most Favored Nation Prescription Drug Pricing to...
Navigating Pharma Distribution Models: Insights from Industry Leaders Part 2
5 Minute Read
Part 2 of our blog examines how new distribution models and market access trends will impact future pharmaceutical strategy.